Specificity cluster of MUC1-reactive mouse monoclonal antibodies

Tumor Biology

Volumn 19, Issue SUPPL.1, 1997, Pages 111-117

  Hanisch, Franz Georg ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Carbohydrates; Epitope analysis; Monoclonal antibodies; MUC1; Mucins

Indexed keywords

MONOCLONAL ANTIBODY; CA 15-3 ANTIGEN; GLYCOPEPTIDE; MUCIN;

ANTIBODY SPECIFICITY; BREAST CARCINOMA; CARCINOMA CELL; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM CELL; EPITOPE MAPPING; GENE CLUSTER; GLYCOSYLATION; LACTATION; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; ANIMAL; ARTICLE; CELL CULTURE; FEMALE; HUMAN; IMMUNOLOGY; MOUSE; NUCLEOTIDE REPEAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CA-15-3 ANTIGEN; EPITOPE MAPPING; FEMALE; GLYCOPEPTIDES; HUMANS; MICE; MUCINS; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 0031605363     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056511     Document Type: Conference Paper

References (10)

1. Carraway KL, Fregien N: Mucin structure and function: Insights from molecular biology. Trends Glycosci Glycotechnol 1994;7:31-44.
2. Hanisch F-G, Uhlenbruck G, Peter-Katalinic J, Egge H, Dabrowski J, Dabrowski U: Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins: A novel type of linearly extended poly-N-acetyllactosamine backbones with Galβ1-3/4GlcNAcβ1-6 repeating units. J Biol Chem 1989;264:872-883.
3. Hanisch F-G, Stadie TRE, Deutzmann F, Peter-Katalinic J: MUC1 glycoforms in breast cancer: Cell line T47D as a model for cancer-associated alterations of O-glycosylation. Eur J Biochem 1996;236: 318-327.
4. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Laiani E, Wilson D: Molecular cloning and expression of the human tumor-associated polymorphic epithelial mucin, PEM. J Biol Chem 1990;265: 15286-15293.
5. Spencer DIR, Price MR, Tendler SJB, DeMatteis Cl, Stadie TRE, Hanisch F-G: Effect of glycosylation of a synthetic MUC1 mucin fragment on anti-mucin antibody recognition. Cancer Lett 1996;100:11-15.
6. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast RC, Finn OJ: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991;51: 2908-2916.
7. Apostolopoulos V, McKenzie IFC: Cellular mucins: Targets for immunotherapy. Crit Rev Immunol 1994; 14:293-309.
8. Stadie TRE, Chai W, Lawson AM, Byfield PGH, Hanisch F-G: Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells. Eur J Biochem 1995; 229:140-147.
9. Woodward MP, Young WW, Blood-good RA: Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods 1985;78:143-153.
10. Hanisch F-G, Stadie TRE, Bosslet K: Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Cancer Res 1995;55:4036-4040.